MEI Pharma Inc (MEIP)
2.785
-0.02
(-0.89%)
USD |
NASDAQ |
Nov 22, 16:00
2.79
0.00 (0.00%)
After-Hours: 19:10
MEI Pharma Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 65.30M |
| June 30, 2023 | 1.457M |
| March 31, 2023 | 5.894M |
| December 31, 2022 | 32.74M |
| September 30, 2022 | 8.73M |
| June 30, 2022 | 11.41M |
| March 31, 2022 | 9.694M |
| December 31, 2021 | 11.83M |
| September 30, 2021 | 7.757M |
| June 30, 2021 | 7.454M |
| March 31, 2021 | 8.109M |
| December 31, 2020 | 12.60M |
| September 30, 2020 | 6.638M |
| June 30, 2020 | 24.35M |
| March 31, 2020 | 1.244M |
| December 31, 2019 | 1.008M |
| September 30, 2019 | 1.157M |
| June 30, 2019 | 1.13M |
| March 31, 2019 | 1.249M |
| December 31, 2018 | 2.048M |
| September 30, 2018 | 0.488M |
| June 30, 2018 | 0.548M |
| March 31, 2018 | 0.433M |
| December 31, 2017 | 0.358M |
| September 30, 2017 | 0.283M |
| Date | Value |
|---|---|
| June 30, 2017 | 0.449M |
| March 31, 2017 | 4.505M |
| December 31, 2016 | 17.20M |
| September 30, 2016 | 1.096M |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.008M
Minimum
Dec 2019
65.30M
Maximum
Sep 2023
13.51M
Average
8.420M
Median
Revenue (Quarterly) Benchmarks
| Avid Bioservices Inc | 40.17M |
| Evoke Pharma Inc | 2.654M |
| Revance Therapeutics Inc | 59.88M |
| NovaBay Pharmaceuticals Inc | 2.441M |
| Palatin Technologies Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.007M |
| Total Expenses (Quarterly) | 8.352M |
| EPS Diluted (Quarterly) | -1.20 |
| Enterprise Value | -8.182M |
| Earnings Yield | -251.0% |
| Operating Earnings Yield | 198.0% |
| Normalized Earnings Yield | 219.47 |